General Information of This Metabolic Reaction (MR) (ID:
MR003271) |
Formula |
|
Reactant |
Nevirapine |
Product |
8-hydroxynevirapine |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2D6 (CYP2D6)
|
DME Info
|
Cytochrome P450 2B6 (CYP2B6)
|
DME Info
|
Metabolic Type
|
Oxidation
-
8-Hydroxylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Disposition and biotransformation of the antiretroviral drug nevirapine in humans Drug Metab Dispos. 1999 Aug;27(8):895-901.
|
2 |
Differences in nevirapine biotransformation as a factor for its sex-dependent dimorphic profile of adverse drug reactions J Antimicrob Chemother. 2014 Feb;69(2):476-82. doi: 10.1093/jac/dkt359.
|
3 |
Sulfation of 12-hydroxy-nevirapine by human SULTs and the effects of genetic polymorphisms of SULT1A1 and SULT2A1. Biochem Pharmacol. 2022 Oct;204:115243. doi: 10.1016/j.bcp.2022.115243.
|
4 |
U. S. FDA Label -Nevirapine
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.